BACKGROUND: Emerging evidence from observational studies has suggested that metformin may be beneficial in the primary prevention of colorectal cancer (CRC). METHODS: MarketScan databases were used to identify diabetic patients with CRC. RESULTS: The mean age of the study participants was 55 years and 57 years, respectively, in the control and case groups (P=1.0).

READ FULL ARTICLE Curated publisher From Wiley Online Library